How genome organization influences cell fate
UC Riverside-led study identifies how blood stem cells maintain their fate
New method expands the world of small RNAs
PANDORA sequencing method developed by UC Riverside-led team can detect once-undetectable small RNAs
Study provides insights into how Zika virus suppresses the host immune system
A research team led by scientists at the University of California, Riverside, has outlined how the Zika virus, which constituted an epidemic threat in 2016, suppresses the immune system of its host. The Zika virus, or ZIKV, spreads through mosquito bites and sexual intercourse. Currently, no approved vaccine or antivirals...
Biochemist spins out joint venture company with Atomwise
Over the past few years, biochemist John Jefferson Perry at the University of California, Riverside, has collaborated on a number of projects with Atomwise Inc., a company that uses artificial intelligence, or AI, for drug discovery. Now Perry and the company have formed a joint venture called Theia Biosciences. Perry’s...
Doubling down on cancer-causing genes
NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors
Two projects receive NIH grant for breast cancer research
UC Riverside research is supported by a four-year grant worth more than $1.2 million
Scientists crack structure of a novel enzyme linked to cell growth and cancer
UC Riverside-led study could lead to the development of drugs that target liver and other cancers
Research to focus on small molecule that can help fight breast cancer
UC Riverside and City of Hope awarded Department of Defense grants for the collaborative project
Scientists crack structure of enzyme complex linked to cancer
UC Riverside-led study offers important information for understanding “de novo DNA methylation"